Trial NCT01265199

View at ClinicalTrials.gov 
Org. Study IDs: AT-406-CS-002

Last trial update was posted on 2013-01-23

MeSH Interventions

Cytarabine Daunorubicin

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute

Other Conditions

Acute Myelogenous Leukemia (AML)

Stopping Reasons

Study was terminated before a MTD was determined for administrative reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID